Cart
sales@molnova.com
Substance P (4-11)
CAS No. 53749-60-3
Substance P (4-11)( ——— )
Catalog No. M40435 CAS No. 53749-60-3
Substance P (4-11), the C-terminus fragment of Substance P (Substance P ), is a Substance P agonist that shows highly selective for NK1 receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSubstance P (4-11)
-
NoteResearch use only, not for human use.
-
Brief DescriptionSubstance P (4-11), the C-terminus fragment of Substance P (Substance P ), is a Substance P agonist that shows highly selective for NK1 receptors.
-
DescriptionSubstance P (4-11), the C-terminus fragment of Substance P (Substance P ), is a Substance P agonist that shows highly selective for NK1 receptors.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number53749-60-3
-
Formula Weight966.18
-
Molecular FormulaC46H67N11O10S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. D G Payan, et al. Specific stimulation of human T lymphocytes by substance P. J Immunol. 1983 Oct;131(4):1613-5.?
molnova catalog
related products
-
Methyl benzoin
Methyl benzoin is a biochemical.
-
Ethanone,1-(2,5-dihy...
2,5-Dihydroxy-4-methoxyacetophenone (compounds 3) can be isolated from the 80% methanol extract of roots of Cynanchum paniculatum Kitagawa. 2,5-Dihydroxy-4-methoxyacetophenone inhibits glutamate-induced cytotoxicity in hippocampal HT22 cell line.
-
BMf-BH3
BMf-BH3 belongs to the Bcl-2 apoptosis mediator family. This peptide belongs to the Bcl-2 apoptosis mediator family. Bmf is a key player in histone deacetylase (HDAC) inhibition, which alters the balance between deacetylation and acetylation.
